Kintara Therapeutics, Inc. announced that as a result of cost-cutting measures adopted by the company on November 20, 2023, Dennis Brown was terminated from his position as the Company's Chief Scientific Officer, effective immediately. Dr. Brown will continue as a consultant to the Company, in which Dr. Brown will provide advisory services to the Company on a part-time, month-to-month basis for a fee of no more than $350 per hour.